News Archives

Tuesday December 23, 2014

Qualtré, which has raised $45 million in total funding, said it would use the new funding to expand its sales and marketing team, scale operations, and extend product development as the company supports new customers and additional applications.

Tuesday December 23, 2014

Clinical trials are about to begin on a new Parkinson’s disease vaccine that could offer patients significant improvements over current treatments. The vaccine, developed through the FP7-funded SYMPATH project, may actually be able to modify disease progression, rather than simply providing symptomatic improvement.

Monday December 22, 2014

Individuals who use methamphetamine or its metabolite amphetamine face a threefold increased risk of developing Parkinson's disease (PD) compared with nonusers, and the risk may be particularly high in women, new research shows.

Monday December 15, 2014

Tony Coles, the chief executive who sold Onyx Pharmaceuticals to Amgen for $10.4 billion in 2013, is starting a new company that will use yeast to try and discover new treatments for Parkinson’s, Alzheimer’s, and amyotrophic lateral sclerosis (ALS, also known as Lou Gehrig’s disease.)

Thursday December 11, 2014

Researchers in Montréal led by Jacques Drouin, D.Sc., uncovered a mechanism regulating dopamine levels in the brain by working on a mouse model of late onset Parkinson's disease. The study, conducted in collaboration with Dr. Rory A. Fisher from the Department of Pharmacology at the University of Iowa Carver College of Medicine, is published online today by the scientific journal PLoS Genetics.

Thursday December 11, 2014

Parkinson's disease sufferers have a different microbiota in their intestines than their healthy counterparts, according to a study conducted at the University of Helsinki and the Helsinki University Central Hospital. Researchers are now trying to determine what the connection between intestinal microbes and Parkinson's disease is.